BHVN
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
BHVN
Delisted
BHVN was delisted on the 3rd of October, 2022.
238 hedge funds and large institutions have $4.78B invested in Biohaven Pharmaceutical Holding Company Ltd. in 2020 Q4 according to their latest regulatory filings, with 50 funds opening new positions, 79 increasing their positions, 89 reducing their positions, and 26 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
8% less funds holding in top 10
Funds holding in top 10: 13 → 12 (-1)
11% less repeat investments, than reductions
Existing positions increased: 79 | Existing positions reduced: 89
Holders
238
Holding in Top 10
12
Calls
$282M
Puts
$176M
Top Buyers
| 1 | +$115M | |
| 2 | +$26M | |
| 3 | +$17.3M | |
| 4 |
ClearBridge Investments
New York
|
+$14.1M |
| 5 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$11M |
Top Sellers
| 1 | -$67.9M | |
| 2 | -$64.7M | |
| 3 | -$38.9M | |
| 4 |
Capital International Investors
Los Angeles,
California
|
-$35.7M |
| 5 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$35.2M |